Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
Oleksandr Petrenko(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Philipp Königshofer(Medical University of Vienna), Ksenia Brusilovskaya(Austrian Academy of Sciences), Benedikt Simbrunner(Austrian Academy of Sciences), Eric J. Simon(Boehringer Ingelheim (Germany)), Philipp Schwabl(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), André F. Rendeiro(Cornell University), Laura de Rooij(Austrian Academy of Sciences), Stefan G. Kauschke(Boehringer Ingelheim (Germany)), Katharina Bareiner(Medical University of Vienna), Larissa Pfisterer(Boehringer Ingelheim (Germany))
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
A molecular single-cell lung atlas of lethal COVID-19
|Nature|2021|735
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561